Tiago Marques, Chief Executive Officer at Pasithea Therapeutics Corp. (KTTA), bought 33,333 shares at $0.75 ($25K) on 2025-11-28, disclosed to the SEC on 2025-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.